This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Founded in 1870 and based in Louisville, KY, Brown-Forman Corporation manufactures, distills, bottles, imports, exports, markets and sells a wide variety of alcoholic beverages under recognized brands. The company employs over 4,800 employees in six continents. It has strong portfolio of more than 40 spirits, ready-to-drink (RTD) cocktails and wine brands. These include Jack Daniel’s Tennessee Whiskey — the flagship spirits brand, followed by Jack Daniel’s Tennessee Honey, Jack Daniel’s Tennessee Fire, Gentleman Jack, Jack Daniel’s Single Barrel, Finlandia, Korbel, el Jimador, Woodford Reserve, Old Forester, Canadian Mist, Herradura, New Mix, Sonoma-Cutrer, Early Times, Chambord, BenRiach, GlenDronach and Slane
Brown-Forman (BF.B) Q2 Earnings Beat Estimates, Sales Miss
by Zacks Equity Research
Brown-Forman (BF.B) beats on second-quarter fiscal 2019 earnings while sales miss estimates. Results include impacts of tariff-related inventory reductions in the fiscal second quarter.
Brown-Forman Corporation (BF.B) Q2 Earnings Top Estimates
by Zacks Equity Research
Brown-Forman Corporation (BF.B) delivered earnings and revenue surprises of 1.96% and -2.27%, respectively, for the quarter ended October 2018. Do the numbers hold clues to what lies ahead for the stock?
Will Tariff Woes Hurt Brown-Forman's (BF.B) Q2 Earnings?
by Zacks Equity Research
Brown-Forman's (BF.B) solid brand portfolio, expansion plans and momentum in focus categories bode well. But, the retaliatory tariffs on American whiskey are likely to hurt near-term results.
Brown-Forman Corporation (BF.B) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Brown-Forman Corporation (BF.B) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Brown-Forman Corporation (BF.B) Down 1.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Brown-Forman Corporation (BF.B) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Know How Beverage Stocks Will Gain From Shift to Marijuana
by Rajani Lohia
Cannabis-infused drinks have emerged as an attractive alternative to the problems of the players in the U.S. beverage space, given the health benefits it offers.
Brown-Forman (BF.B) Tops Q1 Earnings & Sales, Trims View
by Zacks Equity Research
Brown-Forman (BF.B) tops earnings and sales estimates in first-quarter fiscal 2019. It continues to gain from broad-based growth across geographies and a balanced portfolio contribution.
Brown-Forman Corporation (BF.B) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Brown-Forman Corporation (BF.B) delivered earnings and revenue surprises of 5.13% and 1.26%, respectively, for the quarter ended July 2018. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights: Anheuser-Busch, Constellation, Canopy Growth and Brown-Forman.
by Zacks Equity Research
Zacks Industry Outlook Highlights: Anheuser-Busch, Constellation, Canopy Growth and Brown-Forman.
Factors Setting the Tone for Brown-Forman's (BF.B) Q1 Earnings
by Zacks Equity Research
Brown-Forman (BF.B) is favored for its solid brand portfolio, expansion plans and shareholder-friendly moves. However, Jack Daniel's price hike in Europe due to the tariff on imports may hurt results.
Factors Setting the Tone for AB InBev's (BUD) Q2 Earnings
by Zacks Equity Research
AB InBev's (BUD) dismal earnings trend and the volatility in certain key markets are concerns for its second-quarter results. However, a positive overall outlook and the brand strength infuse optimism.
Improving Depletions to Aid Boston Beer's (SAM) Q2 Earnings
by Zacks Equity Research
Boston Beer (SAM) is positioned to gain from its robust brands' portfolio, pricing and product innovations. Favorable depletion trends from new launches are likely to drive second-quarter results.
Factors Setting the Tone for Coca-Cola's (KO) Q2 Earnings
by Zacks Equity Research
Coca-Cola (KO) is witnessing a year-over-year decline in revenues for the last few quarters, primarily due to weak volumes and structural headwinds.
Brown-Forman's New Buyback Plan to Boost Shareholder Returns
by Zacks Equity Research
Brown-Forman (BF.B) rewards shareholders by authorizing a $200-million share repurchase program, which extends for a year.
Trade War Tensions Re-escalate
by Zacks Equity Research
Trade War Tensions Re-escalate
Trade War Rhetoric Heats Up
by Mark Vickery
We "celebrate" Independence Day week, not to mention the first trading day of the second half of the calendar year, re-stoking the fires of a global trade war.
Will Brown-Forman's (BF.B) Shares Continue to Trend Higher?
by Zacks Equity Research
Brown-Forman (BF.B) gains from impressive surprise history, solid brand portfolio, expansion plans and shareholder-friendly moves. Rise in Jack Daniel's prices in Europe may hurt the top line.
Brown-Forman (BF.B) Beats Q4 Earnings, Sales Estimates
by Zacks Equity Research
Brown-Forman's (BF.B) solid performance in Q4 is driven by robust underlying sales due to strength in Jack Daniels, led by premium American whiskey portfolio.
Will Brown-Forman (BF.B) Retain Earnings Beat Trend in Q4?
by Zacks Equity Research
Brown-Forman (BF.B) Q4 results likely to reflect gains from its strong brand portfolio, efforts to expand globally, strategic initiatives and a robust outlook.
The Zacks Analyst Blog Highlights: Duke, Charter Communications, Abbott, UnitedHealth and Brown-Forman
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Duke, Charter Communications, Abbott, UnitedHealth and Brown-Forman
Boston Beer Surges 6.8% in a Month: What's Aiding the Stock?
by Zacks Equity Research
Boston Beer's (SAM) three-point growth plan focused on the revival of its Samuel Adams and Angry Orchard brands, cost-saving initiatives and long-term innovation, is aiding stock performance.
Here's Why Clorox (CLX) Stock is Up 3% Post Q3 Earnings
by Zacks Equity Research
Clorox (CLX) is gaining from a robust surprise trend as well progress on its 2020 Strategy and e-commerce initiatives. However, the company's soft margins are keeping us on the sidelines.
Brown-Forman Hits 52-Week High: What's Behind the Rally?
by Zacks Equity Research
Brown-Forman (BF.B) touches a 52-week high on the back of its robust strategies, including growth and expansion plans, solid brand portfolio along with an impressive surprise trend.
AB InBev (BUD) Q1 Earnings Lag, Global Brands Aid Sales Beat
by Zacks Equity Research
AB InBev (BUD) reports lower-than-expected earnings per share in first-quarter 2018 while sales beat estimates. Sales gain from strong global brands and revenue management initiatives.
The Zacks Analyst Blog Highlights: Archer Daniels, Tyson Foods, Hormel, Campbell and Brown-Forman
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Archer Daniels, Tyson Foods, Hormel, Campbell and Brown-Forman